Cargando…
New developments in the management of narcolepsy
Narcolepsy is a life-long, underrecognized sleep disorder that affects 0.02%–0.18% of the US and Western European populations. Genetic predisposition is suspected because of narcolepsy’s strong association with HLA DQB1*06-02, and genome-wide association studies have identified polymorphisms in T-ce...
Autores principales: | Abad, Vivien C, Guilleminault, Christian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5344488/ https://www.ncbi.nlm.nih.gov/pubmed/28424564 http://dx.doi.org/10.2147/NSS.S103467 |
Ejemplares similares
-
Profile of Solriamfetol in the Management of Excessive Daytime Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea: Focus on Patient Selection and Perspectives
por: Abad, Vivien C
Publicado: (2021) -
Sleep and psychiatry
por: Abad, Vivien C., et al.
Publicado: (2005) -
Diagnosis and treatment of sleep disorders: a brief review for clinicians
por: Abad, Vivien C., et al.
Publicado: (2003) -
Profile of pitolisant in the management of narcolepsy: design, development, and place in therapy
por: Romigi, Andrea, et al.
Publicado: (2018) -
Prevalence of Rapid Eye Movement-related Obstructive Sleep Apnea in Adult Narcolepsy
por: Hoshino, Tetsuro, et al.
Publicado: (2019)